Tuesday, 1/18/22 at 11am EST | 8am PST | 5pm CET | 4pm GMT In this presentation we look at the products available to support projects where high resolution weight determination is essential. We will also explain what is important when designing a system that requires an integrated weighing solution and the various factors that can influence the performance and final results.
Monday December 20, 2021 at 11am EST | 10am CST | 8am PST Pharmaceutical manufacturers are under increasing pressure to fast-track technological innovation while remaining compliant. What are the correct steps to reaching operational intelligence with end-to-end data integrity?
Thursday December 9th, 2021 at 11am EST | 10am CST | 8am PST Meet the Modern Lab. Scitara’s Chief Technology Officer Geoff Gerhardt,PhD, and Head of Product Management Dave Levy, discuss how the Scientific Integration Platform, and its foundational technology, Digital Lab Exchange, overcome the pharma industry’s most long-standing obstacles. With end-to-end connectivity, automation, and ability to manage an increasing volume of complex data, Dave and Geoff offer insight into how Scitara is delivering an exciting foundation for digital transformation. Scitara is developing the mechanisms that will make it relatively straightforward to harness the full value of data, and that means finding, analyzing, extracting and, if necessary, transforming data into a format required by the platforms to which it is transferred. Complete connectivity and retention of context flow will mean labs can push and retrieve contextualized insight into, and out of, data lakes, which can then be better mined and interrogated.
Wednesday, December 8, 2021 at 10am EST | 7am PST | 4pm CET | 3pm GMT How can the pharma packaging supply chain collaborate to make a significant contribution to GHG emissions reduction goals? Join the webcast on December 8th to learn what a net zero emission concept for pharmaceutical manufacturing and supply chain would look like, and the steps necessary to achieve it.
Thursday, December 2, 2021 at 4:00pm GMT | 11:00 am EDT What to look for to bring an inhaled medicine from feasibility study to commercial product, from a particle engineering, formulation, drug delivery and analytical characterization perspective. General rules will be supported through case studies
**Tuesday, Nov. 30, 2021 at 2pm EST | 1pm CST | 11am PST*** Formulation options for peptides in early development versus strategies for final dosage for design, keeping all options open. Peptide formulation strategies for rapid entry to the clinic. *** On demand available after final airing until November 30, 2022.***
**Wednesday, November 17, 2021 at 11am EST, 10am CST, 8am PST*** TE&L examples are presented for which the critical toxicological endpoints are discussed and evaluated by means of various methods, in terms of deriving appropriate safety limits. *** On demand available after final airing until November 17, 2022.***
Wednesday October 27th, 2021 at 10am EDT | 7am PDT | 3pm BST | 4pm CEST Antibody products have evolved to be the cornerstone of the biopharmaceutical market and are a driving force in the pharmaceutical landscape. A variety of tools and technologies have contributed to the success and unrivaled growth of antibody products, learn how current and novel technologies may impact antibody product growth in the coming decades.
Tuesday, October 26, 2021 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST Are you planning to turn your analytical HPLC method into a purification method? Are you converting your analytical-scale purification method to semi-prep or production scale? Learn how to set appropriate purification goals for purity, yield and throughput and what type of equipment will best fit your application.
Thursday, October 21, 2021 at 4pm CEST |10am EDT| 7am PDT| 3pm BST Protect not only your valuable product but also public health by ensuring correct storage choices. Gain insight into the effects of deep cold storage and a holistic approach to ensure Container Closure Integrity of sterile pharmaceuticals.